NVCR earnings
NovoCure (NVCR) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.
NVCR earnings history
| Quarter | Reported | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|---|
| Q3 2026 | Oct 29, 2026 | -0.09 | -0.23 | 61.68% | $193.40M |
| Q2 2026 | Jul 23, 2026 | -0.13 | -0.33 | 60.79% | $183.58M |
| Q1 2026 | Apr 30, 2026 | -0.62 | -0.51 | -21.05% | $174.06M |
| Q4 2025 | Feb 26, 2026 | -0.22 | -0.41 | 46.34% | $174.35M |
| Q3 2025 | Oct 30, 2025 | -0.33 | -0.42 | 21.43% | $167.20M |
| Q2 2025 | Jul 24, 2025 | -0.36 | -0.39 | 7.69% | $158.81M |
| Q1 2025 | Apr 24, 2025 | -0.31 | -0.47 | 34.04% | $154.99M |
| Q4 2024 | Feb 27, 2025 | -0.61 | -0.34 | -79.41% | $161.27M |
| Q3 2024 | Oct 30, 2024 | -0.28 | -0.34 | 17.65% | $155.09M |
| Q2 2024 | Jul 25, 2024 | -0.31 | -0.40 | 22.50% | $150.36M |
| Q1 2024 | May 2, 2024 | -0.36 | -0.43 | 16.28% | $138.50M |
| Q4 2023 | Feb 22, 2024 | -0.45 | -0.53 | 15.09% | $133.78M |
| Oct 26, 2023 | -0.46 | -0.52 | 11.54% | – | |
| Jul 27, 2023 | -0.54 | -0.50 | -8.00% | – | |
| May 4, 2023 | -0.50 | -0.36 | -38.89% | – | |
| Feb 23, 2023 | -0.36 | -0.32 | -12.50% | – | |
| Oct 27, 2022 | -0.25 | -0.30 | 16.67% | – | |
| Jul 28, 2022 | -0.23 | -0.14 | -64.29% | – | |
| Apr 28, 2022 | -0.04 | -0.17 | 76.47% | – | |
| Feb 24, 2022 | -0.25 | -0.10 | -150.00% | – |
- NVCR beat EPS estimates in 26 of its last 43 reports.
Updated 2026-11-03 12:36 UTC